Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol in Heart Failure
NCT00181155Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2004
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Allopurinol with Placebo (2 arms). Primary endpoint: Myocardial Creatine Kinase (CK) Flux. Started Nov 2004; status: completed.
02
Drugs
allopurinol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00181155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181155.